Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Noninvasive Prenatal Testing (NIPT) for Down’s syndrome will be reimbursed in Belgium

17 Jul 2017

The NIP test is a non-invasive prenatal test aimed at detecting Down's syndrome in fetus. This test is a screening performed using mother's blood sample from the 12th week of pregnancy. The NIP test is much more efficient and will reduce the number of amniocenteses and the resulting number of miscarriages.

The test price is set at 260 Euro. The test will be fully reimbursed for women benefiting from preferential treatment. Women who do not benefit from this scheme will pay a maximum of 8.68 EUR (personal quota).

Link to the news at INAMI web-site in French/Dutch is here

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.